WELLINGO
LIVE

Serial Number

79265691

Owner

BIOFARMA

Attorney

Maury M. Tepper, III

Filing Date

Dec 18, 2018

Add to watchlist:

No watchlists yet
View on USPTO

WELLINGO Trademark

Serial Number: 79265691 • Registration: 6224326

WELLINGO is a trademark filed by BIOFARMA on December 18, 2018. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

BIOFARMA (296 trademarks)

50, rue Carnot
Suresnes cedex 92284 , FR

Entity Type: 03

Trademark Details

Filing Date

December 18, 2018

Registration Date

December 22, 2020

Published for Opposition

June 23, 2020

Goods & Services

Medical analysis apparatus, instruments and equipment for the prevention and treatment of heart diseases; artificial teeth, organs and limbs; orthopedic supports; suture material; medical compression stockings, tights and socks; medical stockings, tights and socks for varicose veins; medical apparatus, instruments and equipment for introducing pharmaceutical preparations into the human body for the prolonged, controlled or immediate release of active substances; perfusion devices and syringes for medical use; medical measuring instruments, namely, medical instruments able to directly transmit data to a database in the field of fever measuring instruments, heart rate monitors; endoscopic equipment in the nature of endoscopic video capsules for medical purposes; medical apparatus for measuring biochemical changes in blood; inhalers for medical use; blood pressure monitors; all of the foregoing excluding goods for ophthalmology, optometry, vision correction, or health and treatment of the eye

Medical services; veterinary services; hygienic and beauty care for human beings or animals; advisory services relating to health; telemedicine services; medical diagnosis services; home health care services; individualized medical prescription refill reminder services; online medical prescription services, namely, interactive medical monitoring and alert service for reminding clients of medicinal dosage, allergy sensitivity, and prescription refills for medical treatment purposes; consultancy in relation to medical treatment in the home; advice relating to self-medication, namely, providing medical advice in the field of individuals managing their own medication regimen; provision of medical information to patients; remote medical examination services; medical monitoring of patients and remote monitoring of medical data for medical assistance services; all of the foregoing excluding services in the fields of ophthalmology, optometry, vision correction, or health and treatment of the eye

Scientific, weighing, measuring, signaling, checking, supervision, life-saving and teaching apparatus and instruments, namely, computers, microscopes for scientific or research purposes in the fields of neuropsychiatric diseases, immune-inflammatory diseases, cardiovascular diseases, diabetes and cancers; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images;, namely, apparatus for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data, for controlling and managing patient medical information, for providing information on health and wellness and to enable healthcare professionals to receive and track patient data relating to vital signs, symptoms and medication compliance; computers; software recorded on magnetic media or downloaded from a remote computer network for controlling and managing patient medical information, excluding optical prescriptions or other medical information related to the eye; personal digital assistant; transmitters of electronic signals; video cameras; activity sensors, namely, wearable activity trackers; downloadable applications for mobile devices to enable users to track their symptoms, physical activity and vital signs unrelated to the eye and to record and share such information with healthcare professionals; in-ear headphones; virtual reality helmets; all of the foregoing excluding goods for ophthalmology, optometry, vision correction, or health and treatment of the eye

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 22, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 18, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 25, 2021 FICS
FINAL DISPOSITION PROCESSED
Mar 25, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 22, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 22, 2020 R.PR
POST PUBLICATION AMENDMENT - ENTERED
Nov 18, 2020 CHPB
POST PUBLICATION AMENDMENT - ENTERED
Nov 18, 2020 CHPB
ASSIGNED TO PETITION STAFF
Nov 18, 2020 APET
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Nov 1, 2020 ETOP
TEAS POST PUBLICATION AMENDMENT RECEIVED
Oct 2, 2020 EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
Oct 1, 2020 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Jul 20, 2020 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 23, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 23, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Jun 19, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 3, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 3, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 3, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 18, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 24, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 23, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 23, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 4, 2020 GNRN
NON-FINAL ACTION E-MAILED
Apr 4, 2020 GNRT
NON-FINAL ACTION WRITTEN
Apr 4, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 13, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 13, 2020 CRFA
ASSIGNED TO LIE
Mar 13, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 9, 2020 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 19, 2020 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 19, 2020 CHAN
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 19, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 19, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 19, 2020 COAR
REFUSAL PROCESSED BY IB
Oct 19, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 1, 2019 RFCS
REFUSAL PROCESSED BY MPU
Sep 30, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 17, 2019 RFCR
NON-FINAL ACTION WRITTEN
Sep 16, 2019 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Sep 16, 2019 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 6, 2019 RFCR
NON-FINAL ACTION WRITTEN
Sep 5, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 3, 2019 MAFR
ASSIGNED TO EXAMINER
Aug 30, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 30, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 22, 2019 REPR